The Noguchi Institute, Tokyo, Japan.
Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(7):731-47. doi: 10.2183/pjab.86.731.
Comparative study of the oligosaccharide profiles of individual human milk revealed the presence of three different patterns. Four oligosaccharides containing the Fucalpha1-2Gal group were missing in the milk of non-secretor, and three oligosaccharides containing the Fucalpha1-4GlcNAc group were missing in the milk of Lewis negative individuals. Disappearance of some major oligosaccharides in these samples led to the finding of five novel minor oligosaccharides, which were hidden under the missing oligosaccharides. Following these studies, structures of many novel milk oligosaccharides were elucidated. At least 13 core oligosaccharides were found in these oligosaccharides. By adding alpha-fucosyl residues and sialic acid residues to these core oligosaccharides, more than one hundred oligosaccharides were formed. All these oligosaccharides contain lactose at their reducing termini. This evidence, together with the deletion phenomena found in the milk oligosaccharides of non-secretor and Lewis negative individuals, suggested that the oligosaccharides are formed from lactose by the concerted action of glycosyltransferases, which are responsible for elongation and branching of the Galbeta1-4GlcNAc group in the sugar chains of glycoconjugates on the surface of epithelial cells. Therefore, oligosaccharides in human milk could include many structures, starting from the Galbeta1-4GlcNAc group in the sugar chains of various glycoconjugates. Many lines of evidence recently indicated that virulent enteric bacteria and viruses start their infection by binding to particular sugar chains of glycoconjugates on the target cell surfaces. Therefore, milk oligosaccharides could be useful for developing drugs, which inhibit the infection of bacteria and viruses.
对个体人乳寡糖图谱的比较研究表明,存在三种不同的模式。非分泌者的乳汁中缺少含有 Fucα1-2Gal 基团的四种寡糖,Lewis 阴性个体的乳汁中缺少含有 Fucα1-4GlcNAc 基团的三种寡糖。这些样品中一些主要寡糖的消失导致了发现了五种新的次要寡糖,这些寡糖隐藏在缺失的寡糖之下。在这些研究之后,许多新的乳寡糖的结构被阐明。在这些寡糖中发现了至少 13 种核心寡糖。通过在这些核心寡糖上添加α-岩藻糖基残基和唾液酸残基,形成了一百多种寡糖。所有这些寡糖都在其还原末端含有乳糖。这一证据,加上在非分泌者和 Lewis 阴性个体的乳寡糖中发现的缺失现象,表明这些寡糖是由乳糖通过糖基转移酶的协同作用形成的,这些酶负责糖链中 Galβ1-4GlcNAc 基团的延伸和分支糖蛋白在细胞表面上。因此,人乳中的寡糖可能包括许多结构,从各种糖蛋白糖链中的 Galβ1-4GlcNAc 基团开始。最近的许多证据表明,毒性肠道细菌和病毒通过与靶细胞表面上特定的糖链结合开始感染。因此,乳寡糖可用于开发抑制细菌和病毒感染的药物。